Patient-Led Urate Self-Monitoring to Improve Clinical Outcomes in People With Gout: A Feasibility Study.

ABSTRACT:

Objective

Self-monitored point-of-care urate-measuring devices are an underexplored strategy to improve adherence to urate-lowering therapy and clinical outcomes in gout. This study observed patient-led urate self-monitoring practice and assessed its influence on allopurinol adherence, urate control, and health-related quality of life.

Methods

People with gout (n = 31) and prescribed allopurinol self-monitored their urate concentrations (HumaSens2.0^plus) at baseline and thereafter monthly for 12 months (3 months per quarter). Adherence to allopurinol was measured using medication event monitoring technology (Medication Event Monitoring System cap). Time spent below the target urate concentration (<0.36 mmol/L) was determined. Health-related quality of life was mea

SUBMITTER: Michael TJF 

PROVIDER: S-EPMC11246832 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature